Literature DB >> 19605657

Fistulas in malignant gynecologic disease: etiology, imaging, and management.

Priya Narayanan1, Marielle Nobbenhuis, Karina M Reynolds, Anju Sahdev, Rodney H Reznek, Andrea G Rockall.   

Abstract

A fistula that occurs in association with a malignancy of the female reproductive tract may be caused by a primary or recurrent tumor or may be a complication of surgery or radiation therapy. Identification of the cause, complexity, and location of a fistula is essential for optimal management planning. Radiologic imaging, particularly with computed tomography and magnetic resonance techniques, is invaluable for the assessment of gynecologic fistulas and may help direct the clinician toward the most appropriate management pathway. The modality and technique selected for the initial imaging evaluation depend largely on the clinical history and manifestations. However, imaging with a combination of techniques often is required for accurate diagnosis and effective treatment planning. Radiologists should be familiar with suggestive clinical signs and symptoms as well as with the characteristic appearances of rectovaginal, vesicovaginal, ureterovaginal, enterovesical, enterocutaneous, and other pelvic fistulas at multimodality imaging. Copyright RSNA, 2009

Entities:  

Mesh:

Year:  2009        PMID: 19605657     DOI: 10.1148/rg.294085223

Source DB:  PubMed          Journal:  Radiographics        ISSN: 0271-5333            Impact factor:   5.333


  27 in total

1.  Urologic complications of laparoscopic radical hysterectomy and lymphadenectomy.

Authors:  Jong Ha Hwang; Myong Cheol Lim; Jae Young Joung; Sang-Soo Seo; Sokbom Kang; Ho Kyung Seo; Jinsoo Chung; Sang-Yoon Park
Journal:  Int Urogynecol J       Date:  2012-04-25       Impact factor: 2.894

2.  Uterocutaneous fistula as the primary presentation of a gynaecological malignancy.

Authors:  Liesel Elisabeth Hardy; Yee Leung
Journal:  BMJ Case Rep       Date:  2018-06-08

3.  Vesicouterine fistula presenting with urinary incontinence 30 years after primary Cesarean: Case report and review of the literature.

Authors:  Funda Gungor Ugurlucan; Ercan Bastu; Baris Bakir; Onay Yalcin
Journal:  Can Urol Assoc J       Date:  2014 Jan-Feb       Impact factor: 1.862

4.  What is your diagnosis?

Authors:  Hasan Terzi; Tayyar Alp Ozkan; Ahmet Kale
Journal:  J Turk Ger Gynecol Assoc       Date:  2012-12-01

5.  Pelvic imaging following chemotherapy and radiation therapy for gynecologic malignancies.

Authors:  Helen C Addley; Hebert Alberto Vargas; Penelope L Moyle; Robin Crawford; Evis Sala
Journal:  Radiographics       Date:  2010-11       Impact factor: 5.333

6.  [Vesicovaginal fistula. Incidence, etiology and phenomenology in Germany].

Authors:  C Hampel; A Neisius; C Thomas; J W Thüroff; F Roos
Journal:  Urologe A       Date:  2015-03       Impact factor: 0.639

7.  The "shield sign" in two men with metastatic salivary duct carcinoma to the skin: cutaneous metastases presenting as carcinoma hemorrhagiectoides.

Authors:  Philip R Cohen; Victor G Prieto; Sarina A Piha-Paul; Razelle Kurzrock
Journal:  J Clin Aesthet Dermatol       Date:  2012-09

Review 8.  Primary vaginal cancer: role of MRI in diagnosis, staging and treatment.

Authors:  C S Gardner; J Sunil; A H Klopp; C E Devine; T Sagebiel; C Viswanathan; P R Bhosale
Journal:  Br J Radiol       Date:  2015-05-12       Impact factor: 3.039

9.  CT vaginography: a new CT technique for imaging of upper and middle vaginal fistulas.

Authors:  Diomidis Botsikas; Nicola Pluchino; Anastasia Kalovidouri; Alexandra Platon; Xavier Montet; Patrick Dallenbach; Pierre-Alexandre Poletti
Journal:  Br J Radiol       Date:  2017-03-29       Impact factor: 3.039

10.  Evaluation of genitourinary fistulas in pelvic malignancies with etiopathologic correlation: role of cross sectional imaging in detection and management.

Authors:  Anitha Mandava; Veeraiah Koppula; Gaurav Sharma; Meghana Kandati; K V V N Raju; T Subramanyeshwar Rao
Journal:  Br J Radiol       Date:  2020-06-15       Impact factor: 3.039

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.